← FDA DRUG APPROVALS

FDA NDA · NDA006921

CHLOR-TRIMETON

Sponsor: SCHERING

APPLICATION
NDA006921
TYPE
NDA
ORIGINAL APPROVAL
1949-07-13
LATEST ACTION
1979-09-06
ROUTE
ORAL
DOSAGE FORM
TABLET, SYRUP
MARKETING STATUS
Discontinued

Products

CHLOR-TRIMETONDiscontinued
CHLORPHENIRAMINE MALEATE 4MG · TABLET · ORAL
CHLOR-TRIMETONDiscontinued
CHLORPHENIRAMINE MALEATE 2MG/5ML · SYRUP · ORAL

Approval history

1979-09-06Labeling · Supplement 7AP
1978-09-13Labeling · Supplement 5AP
1978-06-26Labeling · Supplement 4AP
1949-07-13UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →